The Arch City Report

St. Louis Business Journal

A weekly news podcast covering the biggest stories from the St. Louis Business Journal.

  1. Aug 13

    Why the Blues aren’t going for free TV

    Where Will You Watch the Blues This Season? Inside the Collapse of Regional Sports Networks As regional sports networks collapse nationwide, professional sports teams are scrambling to reinvent how fans watch their games. In this episode of Arch City Report, business journal reporter Nathan Rubbelke joins host Erik Siemers to break down how the St. Louis Blues are overhauling both the production and distribution of their broadcasts for the upcoming NHL season — including a new partnership with the NHL's in-house production arm, an expanded slate of over-the-air games, and the search for a new cable and streaming partner. Then, Patrick Rishe, director of the sports business program at Washington University's Olin School of Business, joins to unpack the bigger financial picture: why local media revenue is so hard to replace, how private equity is reshaping team ownership, and why some markets — and some owners — may be better positioned than others to weather the shift. Topics covered: Why FanDuel Sports Network Midwest's collapse is forcing the Blues to rethink their entire broadcast strategyHow NHL-produced broadcasts will change what fans see on screenThe trade-offs between free over-the-air TV, streaming, and pay cableWhy regional sports revenue can be nearly impossible to fully replaceThe rise of private equity investment in professional sportsHow state income tax policy may be influencing player free agency decisionsMixed-use sports districts as a new year-round revenue strategy Read more of this reporting at www.bizjournals.com/stlouis. Thanks to our sponsors, Maryville University and Cass Commercial Bank.

  2. Jul 9

    Bayer’s St. Louis legacy: 10 years of litigation

    en years after Bayer's landmark $63 billion acquisition of St. Louis-based Monsanto, the German pharmaceutical giant is finally seeing the legal tide turn — but the battle is far from over. In this episode, St. Louis Business Journal reporter Jim Drew joins host Erik to break down a recent flurry of major developments in Bayer's long-running Roundup litigation. The U.S. Supreme Court handed Bayer a decisive 7-2 victory, ruling that federal pesticide law preempts state-level "failure to warn" lawsuits — potentially clearing a path to dismiss tens of thousands of claims. At the same time, a St. Louis Circuit Court is weighing a proposed $7.25 billion class action settlement that would resolve 67,000 Roundup cases, even as a faction of cancer victims pushes back on the terms. We also look at Bayer's surprising move to create a separate business unit — Ruvian — to house its Roundup operations, raising questions about liability management and whether a full spinoff could be on the horizon. And as insurers fight back against Bayer's attempts to recoup billions in legal costs, we examine what the science still doesn't know about glyphosate — and why this story may be far from its final chapter. Cancer research continues as Supreme Court sides with Bayer on Roundup labelsJust a mBayer says Supreme Court ruling should dismiss 'vast majority' of Roundup lawsuitsoment...Judge delays Bayer's $7.25B Roundup settlement hearing amid objectionsJudge declares mistrial in Roundup lawsuit after US Supreme Court rulingBayer creates new unit for Roundup business, based in Creve CoeurInsurers attack Bayer bid for coverage (Round Up)

Ratings & Reviews

5
out of 5
14 Ratings

About

A weekly news podcast covering the biggest stories from the St. Louis Business Journal.

You Might Also Like